These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 302275)

  • 1. Migratory behavior of lymphocytes with specific reactivity to alloantigens. I. Selective recruitment to spleen, bone marrow, and liver after an intravenous challenge.
    Emeson EE
    J Immunol; 1977 Oct; 119(4):1204-12. PubMed ID: 302275
    [No Abstract]   [Full Text] [Related]  

  • 2. Mouse bone marrow lymphocytes and their differentiation.
    Ryser JE; Vassalli P
    J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential requirement for B-memory and T-memory cells in adoptive antibody formation in mouse bone marrow.
    Koch G; Benner R
    Immunology; 1982 Apr; 45(4):697-704. PubMed ID: 6978285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymus independent stimulator cells in the mixed lymphocyte reaction.
    Harrison MR
    J Immunol; 1973 Oct; 111(4):1270-3. PubMed ID: 4269624
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigen-induced recruitment of circulating lymphocytes to the lungs and hilar lymph nodes of mice challenged intratracheally with alloantigens.
    Emeson EE; Norin AJ; Veith FJ
    Am Rev Respir Dis; 1982 Apr; 125(4):453-9. PubMed ID: 7041726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3H-uridine incorporation by small lymphocytes of tolerant rats: relationship to T and B lymphocytes.
    Bottomly HK; Perkins WD; Schwarz MR
    J Immunol; 1975 Sep; 115(3):648-52. PubMed ID: 125299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice.
    McNagny KM; Cazenave PA; Cooper MD
    J Immunol; 1988 Oct; 141(8):2551-6. PubMed ID: 3262662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy among thymocytes and peripheral lymph node cells in the in vitro generation of lymphocytes cytotoxic to alloantigens.
    Tigelaar RE; Feldmann M
    Transplant Proc; 1973 Dec; 5(4):1711-5. PubMed ID: 4272825
    [No Abstract]   [Full Text] [Related]  

  • 9. Spleen colony-forming performance of bone marrow cells as a function of immune or nonimmune interactions induced by various H-2 disparities.
    Lengerová A; Matousek V; Zelený V
    Transplant Proc; 1973 Dec; 5(4):1389-91. PubMed ID: 4590622
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity and characterization of cytotoxic cells generated from alloantigen-stimulated murine bone marrow cells.
    Klimpel GR; Klimpel KD
    J Immunol; 1983 Mar; 130(3):1084-9. PubMed ID: 6185569
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjuvant-induced selective recruitment of specifically reactive lymphocytes: a probable mechanism of adjuvant action.
    Emeson EE
    J Immunol; 1980 May; 124(5):2222-30. PubMed ID: 6245138
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
    Qian J; Hashimoto T; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of contact sensitivity to 2,4-dinitrofluorobenzene (DNFB) in allogeneic bone marrow chimaera in mice.
    Yasumizu R; Onoé K; Iwabuchi K; Ogasawara M; Geng L; Morikawa K
    Immunology; 1985 Jan; 54(1):149-53. PubMed ID: 3156086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of lymphocyte production in the bone marrow. I. Turnover of small lymphocytes in mice depleted of B lymphocytes by treatment with anti-IgM antibodies.
    Fulop G; Gordon J; Osmond DG
    J Immunol; 1983 Feb; 130(2):644-8. PubMed ID: 6600249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell regulation of interferon-alpha/beta (IFN-alpha/beta) production by alloantigen-stimulated bone marrow cells.
    Reyes VE; Klimpel KD; Klimpel GR
    J Immunol; 1985 May; 134(5):3137-41. PubMed ID: 2858508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells.
    Müller M; Gounari F; Prifti S; Hacker HJ; Schirrmacher V; Khazaie K
    Cancer Res; 1998 Dec; 58(23):5439-46. PubMed ID: 9850077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC-linked Ir gene control of T cell responses: GAT-specific proliferating T cells and helper T cells are elicited in nonresponder mice immunized with soluble GAT.
    Gougeon ML; Theze J
    J Immunol; 1983 Apr; 130(4):1521-6. PubMed ID: 6187811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-regulatory role of spleen localizing thymocytes.
    Gershon RK; Lance EM; Kondo K
    J Immunol; 1974 Feb; 112(2):546-54. PubMed ID: 4149882
    [No Abstract]   [Full Text] [Related]  

  • 20. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.
    Janeway CA; Ron J; Katz ME
    J Immunol; 1987 Feb; 138(4):1051-5. PubMed ID: 3100626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.